SRRK
Scholar Rock Holding Corporation · Healthcare · Biotechnology
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 5.86K | $247,641 | n/a | n/a |
| Q2 2026 | 105 | +5 | 87.18M | $4.79B | +10 | −4 |
| Q1 2026 | 102 | +4 | 76.34M | $3.75B | +8 | −5 |
| Q4 2025 | 97 | -1 | 72.93M | $3.21B | +2 | −2 |
| Q3 2025 | 19 | -2 | 52.36M | $1.95B | n/a | −3 |
| Q2 2025 | 19 | +1 | 48.51M | $1.72B | +1 | n/a |
| Q1 2025 | 15 | 0 | 24.83M | $798.16M | n/a | n/a |
| Q4 2024 | 15 | +1 | 26.21M | $1.13B | +2 | −1 |
| Q3 2024 | 13 | 0 | 15.70M | $125.78M | +1 | −1 |
| Q2 2024 | 13 | n/a | 12.73M | $106.08M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wealth Enhancement Advisory… | 5.76K | +1.8% | $243,030 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | TD Waterhouse Canada Inc. | 100 | 0.0% | $4,611 | 0.0% | Held | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 274 holders, 132.63M shares, $6.20B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.